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ABSTRACT
BACKGROUND AND PURPOSE: MR imaging findings of aneurysm enlargement, aneurysm wall enhancement, perianeurysmal edema, and
embolic phenomena following deployment of flow-diverting stents may be relevant to those patients who subsequently experience
procedure-related intracranial hemorrhage. We sought to document the routine early postoperative MR imaging findings following
flow-diverting stent insertion.
MATERIALS AND METHODS: Patients requiring flow-diverting stent placement for treatment or retreatment of cerebral aneurysms were
prospectively included in the study during a 26-month period. Early postprocedural MR imaging studies were obtained and compared with
preoperative imaging. Patient clinical outcome data were also collected.
RESULTS: There were 34 stent-placement procedures during the study period. Aneurysm mural enhancement and mild new perianeu-
rysmal edema were present in 50% and 14%, respectively. Any DWI lesion was present in 57% of cases. New or possibly new foci of
susceptibility effect were found ipsilateral to the stent and not associated with diffusion restriction in 66% of cases. There were 2 cases
(6%) of parenchymal hemorrhage and 2 major clinical complications (6%) causing permanent morbidity.
CONCLUSIONS: Asymptomatic aneurysm mural enhancement is frequently seen following flow-diverting stent placement and should
not necessarily be interpreted as a sign of impending aneurysm rupture. This finding often persists despite complete aneurysm occlusion.
New small brain parenchymal susceptibility foci following stent placement have not previously been reported, to our knowledge, but were
common in our series.
Following flow-diverting stent placement to treat intracranialartery aneurysms, complications of delayed aneurysmal and
parenchymal hemorrhage, with or without preceding symptom-
atology, have been described.1-5 Speculation remains regarding
the etiology of both forms of hemorrhage, with an overall hemor-
rhage risk of 7% in reported series.6 Delayed parenchymal hem-
orrhages typically occur on the side of the treated aneurysm and at
an incidence in excess of that expected due to dual antiplatelet
medication alone and from that reported in prior non-flow-di-
verting-stent literature.7,8 MR imaging case reports have identi-
fied perianeurysmal edema, aneurysm expansion, and aneurysm
wall enhancement in symptomatic patients before delayed aneu-
rysm rupture.1,2 It is unknown whether such findings are predic-
tive of subsequent aneurysm rupture. Microembolic change on
diffusion imaging is common following angiographic procedures,
and hemorrhagic transformation of infarcts is one putative cause
of the parenchymal hemorrhages. We sought to document the




Local institutional ethics approval was obtained for this study.
Consecutive patients requiring elective flow-diverting stent place-
ment for the treatment of unruptured cerebral aneurysms or re-
treatment of previously ruptured aneurysms were prospectively
included in the study during a 26-month period from January
2012 to March 2014. Acutely ruptured aneurysms were excluded.
Stent-Placement Procedure
Dual antiplatelet medication (300 mg aspirin and 75 mg clopi-
dogrel) was started 5 days before the intervention; then, clopi-
dogrel was continued for 6 months, and aspirin, life-long. All
procedures were performed with the patient under general anes-
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thesia. A 5000-U heparin bolus was given after femoral puncture;
then, smaller boluses were given to keep activated clotting time at 2–3
times the baseline level. Postprocedural heparin was not routinely
administered. Stents deployed were the Pipeline Embolization De-
vice (Covidien, Irvine, California) in all cases except for 2, in which
the Flow-Redirection Endoluminal Device (MicroVention, Tustin,
California) was used. Each stent-placement procedure was per-
formed by 2 of 4 available interventional neuroradiologists with be-
tween 7 and 20 years of experience (ie, 2 operators per case).
Postprocedural MR Imaging
Early postprocedural MR imaging studies were planned between
2 and 10 days post-stent placement. All MR imaging scans were
obtained on a 1.5T unit (Magnetom Avanto; Siemens, Erlangen,
Germany). Scan protocol was sagittal and axial FSE T1, axial and
coronal FSE T2, axial FLAIR, axial DWI, and either gradient-echo
T2* or SWI also in the axial plane. TOF and dynamic contrast-
enhanced MRA (20 mL of gadopentetate dimeglumine, Magnev-
ist; Bayer HealthCare Pharmaceuticals, Wayne, New Jersey) was
performed followed by postcontrast axial FSE.
Image Analysis
Images from the early postprocedural MR imaging were inter-
preted by an experienced neuroradiologist (B.J.M.) and com-
pared with any available prestenting imaging. Doubtful findings
were resolved by consensus read by a second neuroradiologist
(J.K.H.). Aneurysm size, shape, surrounding edema, wall en-
hancement, and the occurrence of parenchymal DWI-positive le-
sions or any other signal disturbance were recorded. Aneurysm
size was considered stable if the maximum single dimension ob-
tained was the same as or within 1 mm of that on the preproce-
dural imaging. Perianeurysmal edema was assessed on T2 and
FLAIR and was defined as mild if 3-mm maximum thickness,
moderate if between 3- and 10-mm thickness, and severe if 10
mm. Aneurysm wall enhancement was defined as a complete rim
of enhancement about the aneurysm wall. Pre-existing T1 short-
ening due to subacute thrombus or coil artifacts was excluded by
reviewing the precontrast T1 scans. Enhancement due to intra-
aneurysmal flow was excluded by assessment of the TOF and con-
trast-enhanced MRA source images. Nodular enhancement was
defined as mural enhancing foci of 2 mm thick interspersed
with thinner linear mural enhancement.
Clinical and Delayed Follow-Up
Clinical data were prospectively recorded as to neurologic symp-
tomatology and clinical complications, at both the time of the
intervention and at follow-up scans. All patients underwent im-
aging (typically MR imaging but occasionally DSA or CTA at the
discretion of the attending interventional neuroradiologist) and
clinical follow-up as per our standard protocol, which is 6
months, 1 year, and 2 years following stent placement.
RESULTS
Study Population and Clinical Presentation
Thirty-four elective flow-diverting stent procedures treating 33
aneurysms in 31 patients were performed during the study period
(2 patients had a single aneurysm retreated with a flow-diverting
stent during the study period, 1 patient had 2 aneurysms on 1
carotid segment treated with a single stent, and 1 patient had a
bilateral paraclinoid aneurysms treated sequentially in 2 proce-
dures). Twenty-seven patients were women, and 4, men, with an
average age of 56 years (range, 42– 81 years). Median aneurysm
pretreatment diameter was 12 mm (mean, 14 mm; range, 5–35
mm). All patients underwent clinical and imaging follow-up be-
tween 6 and 24 months. Eight cases were retreatment of previously
coiled ruptured aneurysms, and the remainder were for unruptured
aneurysms. Overall, 13 patients had coils present in the aneurysm,
either deployed at the time of flow diversion or present from a pre-
vious coiling procedure. A single flow-diverting stent was used in all
cases except for 5 in which between 2 and 4 stents were deployed.
Four of the 26 unruptured aneurysms were symptomatic (2 unilat-
eral headache, 1 headache and sixth cranial nerve palsy, 1 fourth
cranial nerve palsy). Three aneurysms were in the vertebrobasilar
territory with the remainder arising from the carotid artery (3 poste-
rior communicating aneurysms). Four aneurysms were cavernous
carotid with the remainder intradural in location.
Complete early postprocedural MR imaging studies were per-
formed in 24 cases (21 patients and 22 aneurysms). Ten patients
did not meet study imaging inclusion criteria and are excluded
from MR imaging analysis: Four patients did not have MR imag-
ing due to claustrophobia (n  2) and booking errors (n  2), 4
patients did not receive contrast during their scans, and 2 patients
had their scans outside the DWI target window (both at day 16).
All patients underwent clinical and delayed imaging follow-up,
and any patient who experienced clinical complications is dis-
cussed in the “Results” section, including any relevant findings
from incomplete MR imaging performed.
Early MR Imaging Findings
Aneurysm mural enhancement was present in 11 of 22 (50%)
aneurysms measuring 1- to 3-mm thick. Three of these showed
nodular wall enhancement, with the remainder being smooth and
linear (Fig 1). Mild (3 mm) perianeurysmal edema was present
in 3 aneurysms (14%, Fig 2). In all cases, prior imaging showed
that this edema had developed secondary to flow-diverting stent
insertion. Two of these patients re-presented to the hospital with
headaches at days 5 and 23 postoperatively (another patient with-
out perianeurysmal edema re-presented to the hospital with
headache at day 21). Two of these patients with edema were re-
treated in this series in an attempt to promote aneurysm occlu-
sion. None of the patients with perianeurysmal edema had coils
within the treated aneurysm, while 6 of the 11 aneurysms (55%)
with mural enhancement had coils. Aneurysm size was stable or
within 1 mm of pretreatment dimensions in all cases. Any DWI
lesion was present in 13 of 24 cases (57%). Seven cases (30%) had
5 DWI lesions or any lesion 5 mm. Twenty-one of the 24 cases
had susceptibility-weighted imaging performed, while 3 had gra-
dient-echo T2. New foci of susceptibility effects ipsilateral to the
stent and not associated with diffusion restriction were found in 8
patients (38%) who had susceptibility-weighted sequences per-
formed (Fig 3). A further 28% of these studies (6/21) had suscep-
tibility foci ipsilateral to the stent, which were possibly new but
did not have an earlier comparison SWI sequence. All SWI foci
were 2 mm and not identifiable on any other sequence.
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Clinical Complications
Ten clinical complications occurred in 9 of 34 operations (26%).
Eight of these were transient or resolved with appropriate treat-
ment, and 2 patients (6%) experienced permanent morbidity.
One of these (parenchymal hemorrhage) was disabling (mRS 
3), and the other (ischemic), nondisabling (mRS  1). There were
no deaths.
There were 3 ischemic and 2 hemorrhagic complications, 3 of
5 cases being transiently symptomatic. Four of these occurred
within 48 hours of stent deployment, and 1 at 2 weeks (pontine
hemorrhage). Two cases (6%) of symptomatic parenchymal hem-
orrhage occurred within the treated vascular territory. One of
these occurred at approximately 6 hours following stent deploy-
ment, resulting in a 4-cm hematoma in the superior left temporal
lobe with associated Sylvian subarachnoid hemorrhage and pro-
ducing expressive and receptive dysphasia. This patient subse-
quently had MR imaging the following day, which showed 2 small
foci of restricted diffusion (5 mm) remote from the hemorrhage.
No new foci of susceptibility effect were identified remote from the
hemorrhage. This patient was excluded from the early MR imaging
analysis due to not having contrast at the time of her acute scan. The
second case of parenchymal hemorrhage was a 3-mm pontine hem-
orrhage found on CT at 2 weeks’ post-stent deployment when the
patient presented to another institution following a syncope episode
(Fig 4). There were no lasting clinical sequelae, and no clear cause of
the syncope was identified. No DWI or SWI focus was identified at
the site of the hemorrhage on the patient’s preceding early MR im-
aging scan at day 2. Both hemorrhages occurred in the vascular ter-
ritory accessed by the guide catheter, the first case occurring distal to
the stented cavernous carotid aneurysm and the second occurring
proximal to a posterior cerebral artery aneurysm.
Three patients re-presented to the hospital with headaches
without subsequent hemorrhage or neurologic sequelae. One of
these patients re-presented to the hospital with headaches twice
and was retreated with a flow-diverting stent within this series in
an attempt to promote occlusion of the aneurysm. One patient,
who also experienced a transient ischemic deficit, required open
surgical repair of a femoral artery puncture site, with full recovery.
Delayed Imaging Follow-Up
All patients have had between 6- and 24-month follow-up. Imag-
ing follow-up was with contrast-enhanced MRA in all patients
except for 2 in whom CTA was per-
formed. DSA was performed in addition
to these studies in 5 cases. Aneurysm oc-
clusion was complete in 19 of 33 aneu-
rysms (58%) and in 14 of 18 (78%) that
had at least 12 months of follow-up. Of
the 11 aneurysms that showed aneurysm
wall enhancement, 2 have resolved in as-
sociation with aneurysm occlusion, 5
showed stable wall enhancement despite
aneurysm occlusion, 3 showed stable
wall enhancement in the presence of on-
going aneurysm filling, and 1 case with
an occluded aneurysm was not assess-
able because it was followed with CTA.
Of the 3 aneurysms with perianeurysmal
edema, 1 resolved in association with
aneurysm occlusion and reduction in
aneurysm size, 1 is stable with persistent
aneurysm filling, and 1 with an occluded
aneurysm is not assessable due to CTA
follow-up. The areas of new susceptibil-
ity foci on early post-stent-insertion MR
imaging remain unchanged in size,
number, and morphology.
DISCUSSION
Delayed intracranial hemorrhage is now
a well-recognized risk following flow-di-
verting stent placement. However be-
cause the etiology of both forms of hem-
orrhage remain unclear, endovascular
practitioners still have no reliable strate-
gies to minimize this complication. In
patients who re-present to the hospital
with headache or other symptoms be-
fore potential delayed aneurysm rup-
FIG 1. Postcontrast T1-weighted images showing aneurysm mural enhancement following flow-
diverting stent placement. A, Smooth linear wall enhancement in a large left paraclinoid aneu-
rysm. B, Linear wall enhancement along with some central aneurysm luminal filling in a large right
posterior communicating artery aneurysm. C, Nodular wall enhancement of a left paraclinoid
aneurysm.
FIG 2. Development of mild perianeurysmal edema following flow-diverting stent placement. A,
Axial FLAIR imaging before treatment. B, Corresponding FLAIR image following stent placement
shows new perianeurysmal edema.
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ture, there is the opportunity for therapeutic intervention such as
modifying dual antiplatelet medications, inserting an additional
flow-diverting stent, or performing parent artery occlusion. This
study has shown that similar to results in the coiling literature,
aneurysm mural enhancement is frequently seen on MR imaging
in asymptomatic patients who do not proceed to aneurysm rup-
ture.9 Aneurysm wall enhancement is thought to represent an
inflammatory healing response and, when present following
coiling, is usually seen to persist for months to years.9 Such an
inflammatory response can be responsible for optic nerve or
other cranial nerve dysfunction in the absence of aneurysm
enlargement. Our series also shows that it can persist for
months to years following flow diversion despite complete an-
eurysm occlusion.
In the coiling literature, perianeurysmal edema has been ob-
served before treatment in large and often partially thrombosed
aneurysms but also in smaller aneurysms following coiling with
both HydroCoils (MicroVention) and bare platinum coils.9,10
Our study showed that while perianeurysmal edema can occa-
sionally occur following flow diversion, it is usually mild.
There were no cases of delayed aneurysm rupture in our series,
and it is not possible to draw any conclusions about predictive
findings from postprocedural MR imaging for delayed aneurysm
rupture. Previous published case reports of delayed aneurysm
rupture with MR imaging preceding
rupture show findings ranging from
stable aneurysm size and perianeurys-
mal edema but with linear wall en-
hancement to marked aneurysm en-
largement and new brain edema.1,2 On
the basis of our findings and the previ-
ous published literature, aneurysm wall
enhancement is common and should
not be interpreted as a sign of impending
rupture. Perianeurysmal edema is a less
common finding and would be a more
concerning finding, particularly in the
symptomatic patient. Two patients in
this series with perianeurysmal edema
underwent further treatment, one of
which resulted in successful aneurysm
occlusion and resolution of the edema,
while the other aneurysm continues to
fill with stable edema.
Foci of restricted diffusion are known
to be a common finding after aneurysm
embolization and, to a lesser degree,
diagnostic cerebral angiography.11,12
They are also increasingly recognized af-
ter open and endovascular cardiac inter-
ventions.13,14 The degree to which they
are due to gas or thrombotic or other
embolic material is unknown; however,
the use of heparin and air filters has
been shown to reduce their incidence.12
FIG 3. Development of new susceptibility foci in the ipsilateral hemisphere following flow-
diverting stent placement for a right posterior communicating artery aneurysm. Axial SWI (top
row, A–C) obtained 7 days before deployment of a right supraclinoid ICA flow-diverting stent
shows a single susceptibility focus laterally in the superior right parietal lobe (B). Axial SWI
obtained 6 days following stent deployment (bottom row, D–F) shows small new susceptibility
foci in the superior right frontal lobe (D, arrow), superior right parietal lobe (E, arrow) medial to
the pre-existing focus, and in the right occipital pole (F, arrow). The patient had a moderate-sized
posterior communicating artery arising from the aneurysm, approximately co-dominant in size
with the right P1 segment.
FIG 4. Pontine hemorrhage 2 weeks following flow-diverting stent placement for a large left posterior cerebral artery aneurysm in a 52-year-old
man. Axial DWI (A) and SWI (B) performed at 2 days post-stent deployment show 2 small foci of restricted diffusion in the right cerebellar
hemisphere but no signal disturbance in the brain stem. Sagittally reformatted noncontrast CT scan (C) obtained 2 weeks after stent deployment
following a syncopal episode shows a 3-mm pontine hemorrhage (arrow). Axial DWI (D) and SWI (E) performed at 6 months show the
susceptibility effect at the site of the prior pontine hemorrhage.
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Diffusion-positive lesions are mostly asymptomatic, but larger or
more numerous lesions are associated with ischemic symptoms.11
This was confirmed in our study with 2 of the 3 patients who had
ischemic TIA or stroke with MR imaging scans showing a large
number of diffusion lesions. The third patient did not have MR
imaging, but an early CT scan and delayed MR imaging showed
embolic changes that would certainly have been correlated with a
large DWI load. Evidence for procedural techniques that mini-
mize the incidence and number of DWI foci is lacking; such tech-
niques will undoubtedly reduce the procedural risk of clinical
stroke. Adverse long-term neuropsychological outcomes have
been shown with high DWI load following cardiac surgery.
Whether this translates to neuroendovascular treatments is un-
known, and even if it does, it may still be of lower risk than open
neurosurgical alternatives.15,16
There were 2 cases of parenchymal hemorrhage in our series.
The first of these was reasonably typical relative to those previ-
ously reported in the literature. Proposed mechanisms include
unrecognized microwire perforation, hemorrhagic transforma-
tion of an infarct, embolized foreign body material, hemody-
namic changes secondary to the stent, and hyper-response to dual
antiplatelet medication.6,17,18 Our second case of parenchymal
hemorrhage was atypical, given the size, location, and lack of
long-term neurologic morbidity. Most described parenchymal
hemorrhages following flow diversion are supratentorial and re-
sult in a severe clinical deficit.3,5,17 Most interesting, in this case,
we had the opportunity of obtaining MR imaging before the brain
stem hemorrhage, but it did not show a focus of diffusion restric-
tion or susceptibility effect as a clue to the cause of the hemor-
rhage. The only caveat was that DWI can fail to detect a small
brain stem infarct when performed early after the stroke (day 2
postoperative in this case).19
New susceptibility foci, which almost always occurred distally
within the vascular territory being treated with a flow-diverting
stent, were an unexpected finding of this study. There was no
correlation of these foci with areas of restricted diffusion. The case
illustrated in this article (Fig 3) had an earlier comparison MR
imaging that was only 14 days prior, meaning that incidental new
microhemorrhages unrelated to the intervention are an implau-
sible explanation. Potential causes include primary microhemor-
rhages, microhemorrhagic transformation of thromboembolism,
gas embolism, or foreign body embolism. On making the obser-
vation of these new SWI foci, we reviewed our previous 20 elective
non-stent-coiling cases and found the following: Three had defi-
nitely new SWI foci compared with a prior SWI study, 4 had
probable new foci compared with a prior gradient-echo T2 study,
5 had possibly new foci with no old studies, and 8 had no SWI foci
(B.J.M., unpublished data, March 2014). We suspect that this
finding is not unique to flow-diverting stents.
CONCLUSIONS
Asymptomatic aneurysm mural enhancement is frequently seen
following flow-diverting stent placement and should not neces-
sarily be interpreted as a sign of impending aneurysm rupture.
This finding often persists despite complete aneurysm occlusion.
Perianeurysmal edema is less common and, particularly when
symptomatic, is potentially an indication to perform further
treatment. DWI data suggest a comparable embolic risk to that
reported with aneurysm coiling. New small susceptibility foci fol-
lowing stent placement have not been previously reported, to our
knowledge, but were common in our series.
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